Metraipolis › archive › dc_be7f3858d658

Integrative Multiomics Analysis Reveals a Cancer Stem Cell-Driven Prognostic Signature and Nominates Belinostat for Targeted Therapy in Hepatocellular Carcinoma — Europe PMC PMID:42548727

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42548727
DOI
10.1155/sci/7388629
License (as archived)
solo-consultazione
Archived
2026-10-08T03:11:07.233Z
SHA-256 of the archived text
c2555447d0ea710f3b944d1ce73730bc7fbd400a794f0e1f0aaea544bb049f22
Stable URL of this page
https://metraipolis.com/documento/dc_be7f3858d658

How to cite

Integrative Multiomics Analysis Reveals a Cancer Stem Cell-Driven Prognostic Signature and Nominates Belinostat for Targeted Therapy in Hepatocellular Carcinoma — Europe PMC PMID:42548727 — Europe PMC (en), https://europepmc.org/article/MED/42548727 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_be7f3858d658 (Metraipolis archive dc_be7f3858d658, sha256 c2555447d0ea710f3b944d1ce73730bc7fbd400a794f0e1f0aaea544bb049f22)
BibTeX
@misc{dcbe7f3858d658,
  title = {Integrative Multiomics Analysis Reveals a Cancer Stem Cell-Driven Prognostic Signature and Nominates Belinostat for Targeted Therapy in Hepatocellular Carcinoma — Europe PMC PMID:42548727},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42548727},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_be7f3858d658; sha256 c2555447d0ea710f3b944d1ce73730bc7fbd400a794f0e1f0aaea544bb049f22},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42548727. Agents can read the archived copy with the MCP tool read_document.